semaglutide step Two-year effects of in adults with overweight or obesity: the 5 trial FDA has approved a new,

One 2024 study at the Smell and Taste Center at the University of Pennsylvania (source) found evidence of GLP1 agonists significantly depressing the perception of all five basic taste qualities. Interestingly, while all participants in the study experienced a slight decline in their sense of smell, it was not considered statistically significant suggesting that olfactory changes may be more individualised, or more complex to detect in standardised tests

A calculator cannot measure muscle loss or prove that a protein amount will prevent it

Injectable GLP-1 medications require refrigeration

Llewellyn-Smith IJ, Marina N, Manton RN, Reimann F, Gribble FM, Trapp S

Vergari, E